Researchers have developed a tuberculosis test that delivers results in under 30 minutes without requiring sputum samples, addressing longstanding limitations of current diagnostic methods. Traditional TB tests rely on phlegm collection, a process that is difficult for patients, time-consuming for labs, and prone to false negatives and positives.
The new test offers faster turnaround and greater accuracy, potentially transforming TB screening in settings where rapid diagnosis is critical. Tuberculosis remains a global health threat, killing hundreds of thousands annually, particularly in low-income countries where diagnostic delays worsen outcomes.
The breakthrough addresses a practical barrier that has hindered TB detection for decades. Sputum samples are uncomfortable to produce, unsuitable for some patients including young children, and require specialized handling. Faster, more reliable results could enable quicker treatment initiation and better disease containment.
The development represents progress toward a tool that simplifies TB diagnosis in resource-limited settings where the disease burden is heaviest. Details on the test's mechanism, clinical validation data, and timeline for deployment remain to be confirmed.